GGrantIndex
← Search

IND-ENABLING STUDIES FOR SCALABLE PEPTIDE THERAPY TO LIMIT BURN CONVERSION AND SPEED WOUND CLOSURE

$1,949,350FY2020Defense Health AgencyDOD

Neomatrix Therapeutics Inc

Investigators

View source on USAspending →
IND-ENABLING STUDIES FOR SCALABLE PEPTIDE THERAPY TO LIMIT BURN CONVERSION AND SPEED WOUND CLOSURE · GrantIndex